Full Breakdown
MetaGO Launches Doctor-Led Platform for Early Metabolic Health Management
7/7/2026, 11:12:51 AM
MetaGO Launches Doctor-Led Metabolic Health Platform
On 6 July 2026, actor-entrepreneur Kunal Kapoor and Ketto co-founders Varun Sheth and Zaheer Adenwala announced MetaGO, a Mumbai-based health-tech startup that delivers a doctor-led programme for obesity and related metabolic disorders. The service combines diagnostic testing, tele-consultations, personalised nutrition coaching and, where appropriate, prescription GLP-1 medication.
Origin: From Ketto to Metabolic Care
The founders draw on more than a decade of operating Ketto, during which they assisted thousands of families confronting diabetes, obesity and cardiovascular disease. Recognising that many of these conditions develop years before clinical emergencies, they identified a need for continuous, preventive metabolic care, leading to MetaGO’s creation.
Leadership and Advisory Board
MetaGO’s leadership includes actor-entrepreneur Kunal Kapoor, social-entrepreneur Varun Sheth (CEO) and technology executive Zaheer Adenwala (COO). The medical advisory board features cardiologist Dr Kaushal Patel, who guides clinical protocols.
Care Model: Continuous, Personalized Treatment
Members start with a comprehensive metabolic assessment covering over 35 biomarkers, followed by a personalised plan devised by endocrinologists, diabetologists, cardiologists or internal-medicine specialists. GLP-1 therapy is offered when clinically indicated, alongside ongoing physician supervision, nutrition guidance, fitness coaching and regular follow-ups, forming a continuous-care loop.
Biomarker Testing and GLP-1 Use
The diagnostic protocol tracks more than 35 biochemical and physiological markers to map each user’s metabolic profile. GLP-1 drugs, approved for obesity, are integrated into broader treatment regimens, underscoring that medication alone does not ensure durable outcomes.
Community Outreach and Future Plans
Within weeks of launch, MetaGO held a free metabolic health camp for the Mumbai Police, providing on-site blood tests and physician consultations. The firm plans similar initiatives for other professional groups to raise awareness of early metabolic care.
Official Statements & Responses
Kunal Kapoor said the platform targets the pre-clinical phase of metabolic disease, positioning doctor-led consultations as the preferred early intervention over surgery. Varun Sheth highlighted India’s expanding healthcare access and described MetaGO as a shift toward continuous, connected metabolic care. Dr Patel noted that GLP-1 therapies achieve maximal benefit when paired with clinical supervision, metabolic monitoring and sustained lifestyle support.
Verbatim Quotes
- “Over time, it became clear that many of those conditions had begun developing years before anyone needed medical treatment.” — Kunal Kapoor, Co-Founder, MetaGO
- “We’re focused on the years when the right intervention is a doctor’s consultation instead of a surgery.” — Kunal Kapoor, Co-Founder, MetaGO
- “At MetaGO, we believe you need to “Stop fighting your biology alone” “ Varun Sheth, Co-Founder & CEO, MetaGO, added: “India has made significant progress in expanding access to healthcare, and we believe the next opportunity lies in making long-term metabolic care more continuous and connected.” — Varun Sheth, Co-Founder & CEO, MetaGO
- “Kaushal Patel, Cardiologist, MetaGO Medical Advisory, said: “GLP-1 therapies have expanded the treatment options available for people living with obesity, but their impact is greatest when combined with proper clinical supervision, metabolic monitoring, and sustained lifestyle support.” — Dr Kaushal Patel, Cardiologist, MetaGO Medical Advisory
